Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
06FDtuZE91mtsWV5
